OMX Nordic 40
|
2 298,46
|
5,44
|
0,24 %
|
Analysen zu OMX Nordic 40-Werten
| 08.10.24 | ABB Market-Perform | Bernstein Research | |
| 08.10.24 | Nokia Neutral | UBS AG | |
| 08.10.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.10.24 | ABB Buy | Goldman Sachs Group Inc. | |
| 04.10.24 | ABB Neutral | UBS AG | |
| 03.10.24 | Novo Nordisk Neutral | UBS AG | |
| 03.10.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.10.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 27.09.24 | ABB Hold | Jefferies & Company Inc. | |
| 27.09.24 | ABB Sell | Deutsche Bank AG | |
| 27.09.24 | Hennes & Mauritz AB Buy | Deutsche Bank AG | |
| 27.09.24 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 27.09.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 27.09.24 | Hennes & Mauritz AB Buy | UBS AG | |
| 27.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.09.24 | Hennes & Mauritz AB Outperform | RBC Capital Markets | |
| 26.09.24 | ABB Sector Perform | RBC Capital Markets | |
| 26.09.24 | Hennes & Mauritz AB Buy | Deutsche Bank AG | |
| 26.09.24 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 26.09.24 | Hennes & Mauritz AB Buy | UBS AG | |
| 25.09.24 | Volvo AB Buy | Deutsche Bank AG | |
| 25.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.09.24 | Hennes & Mauritz AB Buy | Deutsche Bank AG | |
| 23.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 20.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.09.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 20.09.24 | Novo Nordisk Neutral | UBS AG | |
| 20.09.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 19.09.24 | Nokia Underweight | Barclays Capital | |
| 18.09.24 | ABB Sector Perform | RBC Capital Markets | |
| 18.09.24 | Volvo AB Sector Perform | RBC Capital Markets | |
| 18.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 17.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.09.24 | AstraZeneca Sell | UBS AG | |
| 13.09.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 12.09.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.09.24 | Novo Nordisk Neutral | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.